TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01286376 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT00884884 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT02177435 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03377179 — Predictive Biomarker (PRD): SPHK2 mRNA
Genes: SPHK2; SK2
Study NCT04131699 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00307281 — Predictive Biomarker (PRD): CLC mRNA
Genes: CLC; LGALS10; LGALS10A
Study NCT00307281 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT00767663 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT04990505 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00235014 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01691105 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT03007329 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03007329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04508842 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04508842 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03709745 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06607601 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06607601 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06607601 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00851799 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT00851799 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00851799 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00851799 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03977025 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02511093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00098748 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02052726 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03296826 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03296826 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03453619 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04517695 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02407080 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02407080 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT03978052 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04369664 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03260192 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03809650 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT03809650 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00082511 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01775943 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01775943 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03724383 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01682655 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT00491036 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00491036 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00777985 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04689490 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00388388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02136758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04015427 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT03206970 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03230890 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01748812 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT03362502 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00026910 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00026910 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study NCT00026910 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study NCT00026910 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study NCT00026910 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01247025 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT02255448 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02255448 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00072943 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04537208 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03905148 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT01541943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00594919 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00201357 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02231892 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02117960 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study NCT02117960 — Predictive Biomarker (PRD): BMP4 mRNA
Genes: BMP4; BMP2B; DVR4
Study NCT01114971 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03135158 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02398422 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study NCT02894164 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00851981 — Predictive Biomarker (PRD): MAT1A mRNA
Genes: MAT1A; AMS1; MATA1
Study NCT06362473 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT02839720 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT02839720 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04301128 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00150111 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT02406352 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00425997 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01805908 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01805908 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02533986 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00500058 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT03296137 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT00673348 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02190110 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01943019 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02973204 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04143737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02839226 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01689025 — Predictive Biomarker (PRD): IL21
Genes: Za11; IL-21
Study NCT00734604 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00788931 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03055325 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00837265 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT04110951 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00117715 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00117715 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00117715 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02592616 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01050920 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT01050920 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT04245670 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00538967 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT03237494 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03781895 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01060098 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03770325 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03770325 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT03770325 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT03770325 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03770325 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03770325 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00013819 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00973739 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT03983382 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01832129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03135769 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00051012 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04629079 — Predictive Biomarker (PRD): P4HA1 mRNA
Genes: P4HA1; P4HA
Study NCT04368546 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04368546 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00646763 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01676753 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT03300271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03653156 — Predictive Biomarker (PRD): PSEN1 mRNA
Genes: PSEN1; AD3; PS1; PSNL1
Study NCT03653156 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00585442 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00585442 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT00585442 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00585442 — Predictive Biomarker (PRD): REN mRNA
Genes: REN
Study NCT03218995 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03620578 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT03620578 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT03620578 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study NCT02780583 — Safety Biomarker (SAF): Interleukin 1
Study NCT02050347 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02050347 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT03305380 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02643888 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00686426 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01314560 — Predictive Biomarker (PRD): OCRL mRNA
Genes: OCRL; OCRL1
Study NCT00433160 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01500915 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05527353 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00436423 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00581269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01871363 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05103579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00224861 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00467545 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03566771 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT00962533 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03195348 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04344977 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00656149 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT03764631 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04319341 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT04319341 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05736523 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02628431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04894344 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00620178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01380197 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02130687 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02130687 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02130687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00262236 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00005409 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00951665 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00951665 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04616183 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04246437 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT00974441 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04966494 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00706082 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03023774 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT03389724 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00003434 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00132756 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04278768 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04278768 — Predictive Biomarker (PRD): U2AF1 mRNA
Genes: U2AF1; U2AF35; U2AFBP; FP793
Study NCT02943330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02943330 — Safety Biomarker (SAF): Interleukin 1
Study NCT00381511 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT02429557 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02855957 — Predictive Biomarker (PRD): AHSP mRNA
Genes: AHSP; EDRF; ERAF
Study NCT01024920 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01789060 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00557310 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04599959 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03433833 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT03433833 — Predictive Biomarker (PRD): EPAS1 mRNA
Genes: EPAS1; BHLHE73; HIF2A; MOP2; PASD2
Study NCT02511483 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT02511483 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study NCT01465217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01244594 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02536885 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03643315 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00017654 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03585205 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT01097642 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01097642 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02345772 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00597987 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02782052 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02782052 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00422357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03218072 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02513485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01746121 — Predictive Biomarker (PRD): ENAM mRNA
Genes: ENAM
Study NCT01746121 — Predictive Biomarker (PRD): KLK4 mRNA
Genes: KLK4; EMSP1; PRSS17; PSTS
Study NCT01746121 — Predictive Biomarker (PRD): DLX3 mRNA
Genes: DLX3
Study NCT01746121 — Predictive Biomarker (PRD): FAM83H mRNA
Genes: FAM83H
Study NCT01746121 — Predictive Biomarker (PRD): FAM20A mRNA
Genes: FAM20A; UNQ9388/PRO34279
Study NCT01746121 — Predictive Biomarker (PRD): WDR72 mRNA
Genes: WDR72
Study NCT01746121 — Predictive Biomarker (PRD): ODAM mRNA
Genes: ODAM; APIN
Study NCT03840824 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01610557 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01610557 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01956058 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00742989 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00770497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04222634 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01369641 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT04883125 — Predictive Biomarker (PRD): CITED2 mRNA
Genes: CITED2; MRG1
Study NCT02220855 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03784599 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03784599 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04607304 — Predictive Biomarker (PRD): ABCA2 mRNA
Genes: ABCA2; ABC2; KIAA1062
Study NCT01405352 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01685801 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01685801 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT03368053 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00970892 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT00970892 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03466099 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04845009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04670458 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT01292356 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01292356 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04324996 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT04324996 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04324996 — Predictive Biomarker (PRD): IL15 mRNA
Genes: IL15
Study NCT04324996 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03504540 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03969056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04587414 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01004731 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01367418 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03190694 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04686188 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06600243 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00737568 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04407026 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Trefoil factor 3
Genes: TFF3; ITF; TFI
Study NCT02966964 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01358812 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01358812 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03968575 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01518998 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01824199 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00006441 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00006441 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04444778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04444778 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03866603 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT04376840 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02834520 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT03121807 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study NCT03121807 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03121807 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03121807 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02251834 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04020926 — Surrogate Endpoint (SUR): Serum sodium